Concord Biotech Limited (BOM:543960)

Concord Biotech Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan 21, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	132,141	175,818	159,100	-	-	-
Market Cap Growth	-39.39%	10.51%	-	-	-	-
Enterprise Value	128,837	173,015	157,079	-	-	-
Last Close Price	1264.00	1665.74	1503.90	-	-	-
PE Ratio	40.79	47.31	51.64	-	-	-
PS Ratio	11.74	14.65	15.65	-	-	-
PB Ratio	7.23	9.70	10.42	-	-	-
P/TBV Ratio	7.24	9.71	10.42	-	-	-
P/FCF Ratio	101.90	131.85	88.50	-	-	-
P/OCF Ratio	54.04	71.90	59.93	-	-	-
EV/Sales Ratio	11.45	14.42	15.45	-	-	-
EV/EBITDA Ratio	28.60	33.74	35.82	-	-	-
EV/EBIT Ratio	33.34	37.60	40.62	-	-	-
EV/FCF Ratio	99.35	129.75	87.37	-	-	-
Debt / Equity Ratio	0.00	0.00	0.01	0.02	0.06	0.09
Debt / EBITDA Ratio	0.00	0.01	0.02	0.09	0.22	0.27
Debt / FCF Ratio	0.01	0.02	0.05	0.31	1.19	-
Asset Turnover	0.59	0.64	0.63	0.60	0.57	0.58
Inventory Turnover	1.53	1.93	1.66	0.94	0.99	0.88
Quick Ratio	4.70	4.77	4.58	2.43	2.71	3.92
Current Ratio	6.97	6.17	6.31	3.79	4.08	5.74
Return on Equity (ROE)	18.93%	22.26%	21.88%	20.06%	16.64%	26.55%
Return on Assets (ROA)	12.62%	15.40%	15.04%	13.26%	11.47%	17.80%
Return on Invested Capital (ROIC)	19.25%	25.28%	24.02%	20.75%	17.83%	30.10%
Return on Capital Employed (ROCE)	20.50%	24.90%	24.80%	22.70%	19.80%	28.10%
Earnings Yield	2.45%	2.11%	1.94%	-	-	-
FCF Yield	0.98%	0.76%	1.13%	-	-	-
Dividend Yield	0.82%	0.64%	0.58%	-	-	-
Payout Ratio	34.55%	24.63%	23.19%	22.31%	40.31%	2.43%
Total Shareholder Return	0.55%	0.64%	0.58%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.